Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Eupraxia Pharmaceuticals Inc T.EPRX

Alternate Symbol(s):  EPRX | T.EPRX.W | T.EPRX.W.A

Healthcare Biotechnology
Eupraxia Pharmaceuticals Inc. is a Canada-based clinical-stage biotechnology company. The Company is focused on the development of locally delivered, extended-release alternatives to approved drugs. The Company’s principal business is the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidate, EP-104IAR, is designed to meet the unmet... see more

Bullboard (TSX:EPRX)

View:
Post by 1northumberlandon Mar 13, 2024 9:44am

Target price

  Raymond James target price is $18.00.
62
Post by BeyondValuezon Mar 12, 2024 10:19am

Raymond James - Lead Broker on Deal

Lets see if this US based brokerage can get the stock over issue
76
Post by Jmark1on Oct 30, 2023 3:51pm

Someone doesn’t like something ?

Small amounts being dumped on alternate exchanges makes today look even worse. Not sure why?
82
Post by kindvalueon Aug 17, 2021 4:15pm

destruction

EPRX CFO was at Tekmira which held the delivery technology for the RNAi vaccines Tekmira is now Arbutus we are talking about the delivery for Moderna and others the Tekmira team while he was there ...more  
775
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities